An insurance benefit that provides percutaneous coronary intervention patients with a discharge supply of antiplatelet medication could result in cost savings for insurers. To propose a model in which ...

Using proton pump inhibitors (PPIs) and antiplatelet drugs (thienopyridines) together is an appropriate way of treating patients with cardiovascular (CV) disease who are at high risk of upper ...

DUBLIN--(BUSINESS WIRE)--The "Antiplatelet Market: Analysis By Drug Class, By Route of Administration, By Distribution Channel, By Region Size and Trends" report has been added to ...

Bleeding is a risk with all antiplatelet drugs, whose effects pose a problem when patients need surgery or suffer a traumatic injury. A fast-acting reversal agent would make the drug safer to use.

Heart disease continues to rank as the leading cause of death in the Black community, claiming thousands of lives annually. While lifestyle modifications remain foundational to heart health, modern ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New evidence shows that COVID-19 patients with severe disease have a high level of sustained ...

The application of antiplatelet therapy in dental surgery has become a focal point for clinicians due to the dual needs of maintaining thrombotic protection while minimising perioperative bleeding ...

Patients who received a single antiplatelet drug therapy— usually aspirin — after transcatheter aortic valve replacement (TAVR) had about half the risk of dying in the subsequent 6 months compared ...

When someone survives a heart attack, their recovery journey often includes a small pharmacy of medications—each serving a specific purpose in their healing process and long-term protection.

United States Data Bridge Market Research conducted an extensive qualitative study focusing on the “Antiplatelet Drugs Market“. The large-scale Antiplatelet Drugs market report is widespread and opens ...